A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer
暂无分享,去创建一个
T. Takayama | I. Takemasa | H. Miyamoto | T. Nobuoka | K. Okamoto | N. Muguruma | Yasushi Sato | H. Ohnuma | M. Hirakawa | T. Sagawa | Yasuo Takahashi | K. Fujikawa | K. Hamaguchi | Y. Sato | Y. Takahashi